#SouthAfrica on Sunday suspended the use of the #OxfordAstraZeneca vaccine after a small clinical trial suggested that the drug is not effective in preventing mild to moderate illness from the variant dominant in the country.
I spoke to @mosmasika to understand if the new data posed any risk for Kenya which is heavily relying on the #OxfordAstraZeneca vaccine.
He told me: "We should not stop our plans for vaccination just because South Africa has paused #AZ.
We should appreciate that the two countries are experiencing a somewhat different trajectory in terms of numbers and most likely circulating variants."
But @mosmasika's concern "is that we have not characterised the strains circulating locally very well. The number we have sequenced so far is very small, about 500 out of more than 100,000 cases. We should sequence more genomes to know which strains are here and whether
any of them poses a problem,” said Dr @mosmasika, adding that for now, “I would not strike it [the vaccine] out of the list for Kenya yet, since we do not have any evidence to support such a decision."
He also told me: "We should not stop our plans for vaccination just because South Africa has paused #AZ.
We should appreciate that the two countries are experiencing a somewhat different trajectory in terms of numbers and most likely circulating variants."
Unlike #SA which has chosen to proceed with @JNJAfrica & #PfizerBioNtech vaccines, #KE has limited options in terms of choice of what to deploy.
It's only last week that my colleague @LeonLidigu reported that China’s @ChinaSinopharm had expressed interests to supply its vax
3 cases of the #501YV2 variant have been recorded here w/the latest being a #Trucker detected in Lunga Lunga in #Kwale after sequencing of 60 samples according to @MOH_Kenya.
Acting DG @DrPatrickAmoth said the results of contacts of the said driver have since turned NEGATIVE.
Today @DrPatrickAmoth directed counties with Ports of Entry to heighten their surveillance; Asks them to also reactivate their Rapid Response Teams (RRTs). This is a day after 4 #British troops at the #Nanyuki base tested positive for #COVID19 weeks after arriving from #UK.
It's not yet clear if they tested positive for the #B117 variant dominant in the #UK or not.
@KEMRI_Kenya last month had plans to sequence 400 samples between Jan and Feb in multiple sites across the country to ascertain the extent of the spread of new variants in #UK, #SA & #D80A identified in Taita. Results of this data are yet to be announced.
In light of recent news about #AZ@CEPIvaccines released a statement saying – in the context of viral settings without this variant – that the vaccine offers protection against severe disease, hospitalisation, and death.
"This means it is vitally important now to determine the vaccine’s effectiveness when it comes to preventing more severe illness caused by the B.1.351 variant," @CEPIvaccines's said.
@WHO on Wednesday released guidance on who should be given #AstraZeneca's vax & how it will be administered.
See below: 1. It's to be given 3-4 months between 1st & 2nd dose
2. ANYONE above 18years (pretty standard age for adults).
ALSO to be given to older people above 65yrs since there isn't data that shows that new variants will affect the efficacy of #AZ in this age group.
3. Like #Pfizer's, it will not be given to pregnant & breastfeeding women unless they are at risk of contracting #Covid-19.
"We do not have enough information to recommend the vaccine in this group but don't see no reason for it not to be used if the woman is at risk," @WHO's SAGE chair Dr Alejandro craivoto said.
Covid-19 jabs to reach 16m Kenyans by 2023, @MOH_Kenya Vax strategy shows:
THREAD OF the phased vaccination breakdown
#PhaseI
1.25 million Frontline health workers & individuals involved in service deliveries in health facilities.
People working in essential services like teachers and staff in educational institutions, police, military, prisons, and immigration officers as well as instructors in religious institutions will be vaccinated. This is expected to be done between Q3 & Q4 of the 2020/2021 FY.
#PhaseII
9.76 million people above 50 years and those who are above 18 years but have one or more medical conditions (comorbidity) e.g cancer, diabetes, sickle cell disease, chronic lung, and cardiovascular diseases among others will be vaccinated. @ncdalliance@kenconetwork